Randomised Phase II Trial (NCT00637975) Evaluating Activity and Toxicity of Two Different Escalating Strategies for Pregabalin and Oxycodone Combination Therapy for Neuropathic Pain in Cancer Patients.

MLA

Garassino, Marina Chiara, et al. “Randomised Phase II Trial (NCT00637975) Evaluating Activity and Toxicity of Two Different Escalating Strategies for Pregabalin and Oxycodone Combination Therapy for Neuropathic Pain in Cancer Patients.” PLoS ONE, vol. 8, no. 4, Apr. 2013, pp. 1–6. EBSCOhost, https://doi.org/10.1371/journal.pone.0059981.

APA

Garassino, M. C., Piva, S., La Verde, N., Spagnoletti, I., Iorno, V., Carbone, C., Febbraro, A., Bianchi, A., Bramati, A., Moretti, A., Ganzinelli, M., Marabese, M., Gentili, M., Torri, V., & Farina, G. (2013). Randomised Phase II Trial (NCT00637975) Evaluating Activity and Toxicity of Two Different Escalating Strategies for Pregabalin and Oxycodone Combination Therapy for Neuropathic Pain in Cancer Patients. PLoS ONE, 8(4), 1–6. https://doi.org/10.1371/journal.pone.0059981

Chicago

Garassino, Marina Chiara, Sheila Piva, Nicla La Verde, Ilaria Spagnoletti, Vittorio Iorno, Claudia Carbone, Antonio Febbraro, et al. 2013. “Randomised Phase II Trial (NCT00637975) Evaluating Activity and Toxicity of Two Different Escalating Strategies for Pregabalin and Oxycodone Combination Therapy for Neuropathic Pain in Cancer Patients.” PLoS ONE 8 (4): 1–6. doi:10.1371/journal.pone.0059981.